IS3S:XETRA:XETRA-

| Global Large-Cap Value Equity |

Last Closing

USD 43.545

Change

+0.13 (+0.29)%

Market Cap

USD 3.97B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment objective of the Fund is to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the MSCI World Enhanced Value Index.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-11 )

Largest Industry Peers for Global Large-Cap Value Equity

Symbol Name Price(Change) Market Cap
CBUI:XETRA

+0.01 (+0.15%)

USD 0.26B
JPGL:XETRA

-0.04 (-0.09%)

USD 0.22B
OPEN:XETRA

N/A

USD 0.06B
PSWD:XETRA

-0.05 (-0.16%)

USD 0.06B
BBCK:XETRA

+0.03 (+0.05%)

USD 0.05B
H41D:XETRA

N/A

N/A

ETFs Containing IS3S:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Global Large-Cap Value Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.05% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.05% N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 15.92% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.92% N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain 44.33% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 44.33% N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 14.04% 78% C+ 76% C+
Dividend Return 14.04% 77% C+ 74% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.34% 52% F 61% D-
Risk Adjusted Return 113.78% 95% A 95% A
Market Capitalization 3.97B N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike